HomeInsightFUNDING NEWS- Newly Funded Startups 2024 iSprout Secures Rs 40 cr from Vivriti Asset Management

[Funding alert] iSprout Secures Rs 40 cr from Vivriti Asset Management

iSprout, a well-known collaborative workspace in India, has raised Rs 40 crores through the sale of its first secured bond. Vivriti Asset Management (VAM) made a bond subscription.

iSprout, a well-known collaborative workspace in India, has raised Rs 40 crores through the sale of its first secured bond. Vivriti Asset Management (VAM) made a bond subscription.

The capital will be utilized to increase iSprout’s assets and operations in Bengaluru and Hyderabad. Another important area of the funding is the advancement of exclusive technologies for automated processes, as per reported by Yourstory.

Read also – Clensta Appoints Sandeepa Dhar as Brand Ambassador for its Skincare range

iSprout responds to the need for managed office space between established businesses and startups.

Sundari Patibandla, CEO and co-founder commented on fundraising, “iSprout’s core strength lies in proving premium managed office solutions with five-star rated services. The faith shown by Vivriti Asset Management in our vision to create a better and more inviting work environment has resulted in helping us fund our dreams of slow but steady expansion across India.”

Read also – [Funding alert] SaaS Startup AuditCue Secures $1.5 Mn Seed Funding Led by Kalaari Capital

About iSprout

iSprout is more than just a typical co-working space; it was founded by eminent professionals with years of experience in the field of technology.

They are building a neighborhood where businesses can settle. By doing this, they give you business support from beginning to end along with a prestigious address and inspiring workspaces. Sundari Patibandla, Sreeni Tirdhala, CA Sesshaa Prasad, and Vijay Oddiraju founded it in 2016.

Read also – 16-year-old Indian Girl Founded AI Startup Delv AI and Secured Rs 3 Cr

Viestories

RELATED ARTICLES
- Advertisment -

Most Popular

- Advertisment -

Also Read

- Advertisment -